A Phase 3, Open-Label, Parallel Group, Multicenter, Extension Study Evaluating The Long-Term Treatment Of Bimekizumab In Study Participants With Moderate To Severe Hidradenitis Suppurativa
Posted Date: Nov 6, 2024
- Investigator: Alan Fleischer
- Specialties:
- Type of Study: Drug
The purpose of this study is to evaluate the safety of long-term therapy of bimekizumab in study participants with moderate to severe hidradenitis suppurativa
Criteria:
Null
Keywords:
Hidradenitis Suppurativa
For More Information:
Jordan Sambrokes
NULL
perryj8@ucmail.uc.edu